Abstract Submission Deadline:
1 July 2020 23:59 PT
Now Extended to 3 July 2020 at 23:59 PT
Monday 15 June, 2020
Abstract Submission deadline (Milstein Abstract Award application)
Friday 3 July, 2020, 23:59 PT
Early Bird Registration deadline
Friday 3 July, 2020, 23:59 PT
Notification to submitters
Delegates who would like to present their work as an oral or poster presentation are invited to submit an abstract for consideration by the Scientific Committee.
Please refer to the instructions here below so as to ensure a smooth and successful abstract submission.
The corresponding topic must be selected (see list below) to ensure correct scoring of the abstract. The content of the abstract must be topic related. The papers will be peer-reviewed and selected for poster presentation. A paper should not be submitted to the 8th Annual Meeting of the International Cytokine and Interferon Society if the full paper has been already published.
For standardization, the acceptable length of the abstract is of maximum 3’600 characters and 45 lines. This includes the author’s details, titles and non-visible characters, such as spaces and line breaks.
ICIS members participating as abstract presenters at the virtual annual meeting are eligible to apply for Milstein Abstract Awards. They are provided through a grant from the Milstein Family based on the scientific merit of the abstract. The award is dependent on the availability of funds.
Applications are ranked based on scientific excellence and funds allocated based on Abstract ranking.
• The application is submitted through this questionnaire.
• Deadline to submit is the same as the Abstract submission deadline.
• ICIS membership must be current to be eligible for a Milstein Abstract Award.
Abstracts can only be submitted online via the official online abstract submission form which will be available here from February 2020 through July 3, 2020.
Abstracts sent by post or email will not be accepted. No exceptions will be made.
LIST OF ABSTRACT SUBMISSION TOPICS
- Cytokine regulation
- Innate immunity
- Cytokines in Allergy and Th2 Immunity
- Cytokines in skin inflammatory diseases
- Mucosal immunity
- Autoinflammation and Autoimmunity
- Anti-cytokine therapy
- T cell differentiation and function
- Cytokines in cancer development and antitumor immune therapy
- SARS-CoV-2 or COVID-19
AFTER THE SUBMISSION
The reviewers will judge the abstracts according to scientific or clinical value, relevance to Cytokines 2020, conclusions confirmed by objective results, objectivity of statements, originality of work and overall impression. The submitting authors will be notified by early August 2020 at the email address provided during submission whether their abstract has been accepted. If you need to withdraw your abstract a written statement, reflecting the reasons of this decision must be sent to [email protected] no later than Wednesday 31 August 2020.
Accepted abstracts will be available on the Cytokines 2020 website, about one month prior to the meeting and will be available on the meeting app.
For any further enquiries, please contact the Cytokines 2020 Abstract Handling Team at [email protected]